Adjusting Europe's drug regulation to public health needs

被引：44

作者：

Garattini, S ^{[1
]}

Bertele, V ^{[1
]}

机构：

[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy

来源：

关键词：

D O I：

10.1016/S0140-6736(00)05258-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 67

页数：4

共 12 条

[1] Inconclusive messages from equivalence trials in thrombolysis [J].

Bertele, V ;

Torri, V ;

Garattini, S .

[2]

*EUR COMM, 1998, EUROPEAN COMMUNITI A, V2, P51

[3]

*EUR COMM, 1998, EUROPEAN COMMUNITI A, V2, P15

[4]

*EUR COMM, 1998, EUROPEAN COMMUNITI B, V2, P24

[5]

*EUR FED PHARM IND, 2001, POINTS CONS SWITCH S

[6]

European Commission, 1998, RES HUM RIGHTS VIOL, P1

[7] Multicentre clinical trials [J].

Garattini, S ;

Bertele, V .

[8]

1965, OFF J EUR COMM, P369

[9]

1989, OFF J EUR COMM, P8

[10]

1993, OFF J EUR COMM